Novavax (NVAX) Return on Capital Employed (2011 - 2026)

Novavax's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 10.18% for Q1 2026.

• In Q1 2026, Return on Capital Employed fell 5114.0% year-over-year to 10.18%; the TTM figure through Mar 2026 stood at 10.18% (down 5114.0% YoY), while the FY2025 annual figure was 49.84%, up 9730.0% from the prior year.
• Return on Capital Employed was 10.18% for Q1 2026 at Novavax, down from 63.04% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 6421.91% in Q1 2023 to a low of 3566.59% in Q2 2023.
• Historically, Return on Capital Employed has averaged 89.17% across 5 years, with a median of 51.64% in 2024.
• The sharpest annual moves came in 2023 and 2024: Return on Capital Employed surged 670712 bps in 2023, then sank 647359 bps in 2024.
• A 5-year view of Return on Capital Employed shows it stood at 327.47% in 2022, then sank by 288 bps to 614.53% in 2023, then surged by 92 bps to 51.64% in 2024, then surged by 222 bps to 63.04% in 2025, then tumbled by 116 bps to 10.18% in 2026.
• The last three Return on Capital Employed figures came in at 10.18% (Q1 2026), 63.04% (Q4 2025), and 37.12% (Q3 2025), per Business Quant data.